| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-06 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |